Youtheory® Collagen Liquid Expands Beauty On-The-Go Product in Japan
IRVINE, Calif., Jan. 19, 2023 /PRNewswire/ -- Southern California based supplement brand Youtheory® is expanding its global beauty line with a new and improved Collagen Liquid in a ready-to-drink, single serve packet, now available at Costco Japan. This liquid is designed for beauty conscious consumers who want to maintain their daily routine during their fast-paced, busy lifestyle. The ready...
NEW THERAPY TO TREAT RARE GASTROINTESTINAL STROMAL TUMOUR APPROVED FOR NEW ZEALAND PATIENTS
QINLOCK® (ripretinib) now Medsafe approved for GIST patients in NZ QINLOCK now being considered by PHARMAC for reimbursement Data from the INVICTUS Phase 3 study shows QINLOCK reduces risk of disease progression or death by 85%1, 2 SINGAPORE and AUCKLAND, New Zealand, Jan. 20, 2023 /PRNewswire/ -- Independent biopharmaceutical company Specialised Therapeutics...
Seragon Announces RESTORIN®, the Most Advanced Anti-Aging Nutraceutical to Date
IRVINE, Calif., Jan. 19, 2023 /PRNewswire/ -- Seragon Biosciences, Inc. today announced the launch of RESTORIN®, an advanced nutraceutical for healthy aging. RESTORIN integrates a series of patented technologies from Harvard University, Mayo Clinic, and Scripps Research to boost cellular nicotinamide adenine dinucleotide (NAD+) levels and enhance senolytic stimulation. For decades, the...
Sun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia Areata
Adds Deuruxolitinib, a Potential Best-in-Class Oral JAK Inhibitor for the Treatment of Alopecia Areata, an Autoimmune Dermatological Disease Leverages Sun Pharma's Global Infrastructure to Provide Broad Access to Deuruxolitinib for Patients with Alopecia Areata Strengthens Sun Pharma's Global Dermatology Franchise by Adding a Late-Stage Product in an Area with...
Hepagene Therapeutics Reports Positive Top-line Results for Phase 2a RISE Study of FXR Agonist HPG1860 in Patients with NASH
SHANGHAI, Jan. 19, 2023 /PRNewswire/ -- Hepagene Therapeutics, Inc. a clinical stage biopharmaceutical company focusing on developing novel therapies for patients with chronic liver diseases, today reported positive top-line results from the Phase 2a RISE clinical trial of HPG1860, a next generation non-bile acid, liver selective farnesoid X receptor (FXR) agonist, for the treatment of non-alcoholic steatohepatitis (NASH)....
Health In Tech Partners with 6 Degree Health and 90 Degree Benefits to Form a New Value-Based, Level-Funded Health Plan
STUART, Fla., Jan. 19, 2023 /PRNewswire/ -- Health in Tech ("HIT", or "the Company"), the industry-leading insurtech company that delivers disruptive innovation that reimagines self-funded health plans, today announced that the Company have partnered with 6 Degree Health and 90 Degree Benefits together to form a new value-based, level-funded health plan, effective...
Zhongchao Inc. Launches Medication Management Assistance Mini Program to Facilitate Cancer Treatment
SHANGHAI, Jan. 19, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services to patients with oncology and other major diseases, today announced that Zhongxin Medical Technology Co., Ltd. ("Zhongxin"), one of the China operating entities of which the Company consolidates the financial results with through certain contractual arrangements, launched the...
Prenetics Announces Dr. Bayju Thakar as Chief Executive Officer of Prenetics EMEA
LONDON and HONG KONG, Jan. 19, 2023 /PRNewswire/ -- Prenetics Global Limited (NASDAQ: PRE) a leader in genomic and diagnostic testing, today announced an executive leadership change to ensure the company realizes the full potential of its broad genetics and digital testing platform and as a commitment to the EMEA market. To be effective immediately, Dr. Bayju Thakar is appointed...
Tigermed Completes Acquisition of Marti Farm
HANGZHOU, China and ZAGREB, Croatia, Jan. 19, 2023 /PRNewswire/ -- Tigermed (300347.SZ/3347.HK), a leading global provider of clinical research solutions across the full lifecycle of global biopharmaceutical and medical device products, announced today the completion of its acquisition of Marti Farm, a European Contract Research Organization providing services across pharmacovigilance, clinical operations, regulatory affairs, medical affairs, and offering pharmacovigilance...
China’s First and Only Approved Third-Generation BCR-ABL Inhibitor Olverembatinib Included into the 2022 National Reimbursement Drug List
SUZHOU, China, and ROCKVILLE, MD, Jan. 19, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, and Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), today announced that the novel drug olverembatinib has been included into the China 2022...
